1. Landmark lipid-lowering trials in the primary prevention of cardiovascular disease;Chrispin;Clin Cardiol,2013
2. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials;Koskinas;Eur Heart J,2018
3. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015
4. PCSK9 inhibitors: a new era of lipid lowering therapy;Chaudhary;World J Cardiol,2017
5. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients;Sirimarco;Stroke,2014